Analyst firms · Morgan Stanley · ISRG
Morgan Stanley ISRG price target and rating history
Intuitive Surgical Inc. (ISRG) · Health Care
Morgan Stanley rates Intuitive Surgical Inc. (ISRG) Overweight with a $650 price target, as of its latest action on Dec 2, 2024. It has published 7 rating actions on ISRG since July 2021, including 1 upgrade and 0 downgrades. Across 7 firms with a ISRG price target in the last 12 months, the median target is $500.
- Current rating
- Overweight
- Price target
- $650
- Median target, all firms
- $500
- Actions on ISRG
- 7
Morgan Stanley price target on ISRG
Every Morgan Stanley rating on ISRG
- Dec 2, 2024
- Apr 19, 2023
- Jan 21, 2022
- Jan 7, 2022
- Oct 21, 2021
- Oct 5, 2021
- Jul 21, 2021
How other firms rate ISRG
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Erste Group | Buy | Oct 21, 2026 | |
| Barclays | Overweight | $485 | Oct 7, 2026 |
| Oppenheimer | Outperform | $500 | Aug 12, 2026 |
| HSBC | Hold | $391 | Jul 30, 2026 |
| UBS | Buy | $500 | Jul 28, 2026 |
| BMO Capital Markets | Outperform | $518 | Jul 9, 2026 |
| Citigroup | Buy | $590 | Mar 11, 2026 |
| TD Cowen | Buy | $660 | Jan 27, 2026 |
Questions about Morgan Stanley and ISRG
- What is Morgan Stanley's price target for ISRG?
- Morgan Stanley's latest stated price target for Intuitive Surgical Inc. (ISRG) is $650, from its action on Dec 2, 2024.
- What is Morgan Stanley's rating on ISRG?
- Morgan Stanley rates ISRG Overweight, a bullish rating, as of Dec 2, 2024.
- When did Morgan Stanley last change its view on ISRG?
- On Dec 2, 2024, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $522 to $650.
- How does Morgan Stanley's ISRG target compare with other analysts?
- Across 7 firms with a ISRG price target in the last 12 months, the median target is $500.
More ISRG rating histories
- Erste Group3
- UBS5
- Citigroup7
- Deutsche Bank3
- Evercore ISI3
- BTIG3
- Stifel4
- Wells Fargo4
- BofA Securities3
- Piper Sandler3
All Morgan Stanley ratingsISRG news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.